QCM
IMNM icon

Quantinno Capital Management’s Immunome IMNM Stock Holding History

Quantinno Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
13,995
+3,855
+38% +$82.5K ﹤0.01% 3209
2026
Q1 		$222K Buy
+10,140
New +$226K ﹤0.01% 3171

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Quantinno Capital Management's IMNM Position: Q2 2026 in Review

Quantinno Capital Management increased its Immunome (IMNM) stake by 38% in Q2 2026, buying an estimated $82.5K and bringing the position to 13,995 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #3209.

Quantinno Capital Management first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Quantinno Capital Management held 13,995 shares of Immunome worth $297K as of Q2 2026.
  • Quantinno Capital Management bought 3,855 Immunome shares in Q2 2026, an estimated $82.5K.
  • Immunome made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3209 holding.
  • Quantinno Capital Management first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.